Meridian Bioscience (NASDAQ: VIVO)
Some price data may be temporarily unavailable.
Meridian Bioscience Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Meridian Bioscience Company Info
A fully-integrated life science company whose principal businesses are development, manufacture, sale and distribution of diagnostic test kits; manufacture and distribution of bulk antigens and reagents; and manufacture of proteins and other biologicals.
News & Analysis
Is It Time to Cash In on Meridian Bioscience?
Meridian Bioscience has thrived during the COVID-19 pandemic. Can this stock go much higher, or is it time to cash out?
Why Meridian Bioscience Stock Shot Up Nearly 13% Today
The coronavirus-focused stock rises notably on news of yet another partnership with a diagnostics company.
This Small-Cap Diagnostics Company Just Joined the Coronavirus Battle
Flu season normally is a busy time for Meridian Bioscience, but this year just took an unexpected turn.
Here's Why Meridian Bioscience, Inc. Stock Is Having a Rough Day
Continued pressure on its diagnostic operations might be more serious than expected.
3 Healthcare Stocks With Tantalizing Yet Treacherous Dividends
Want dividend yields of 4% and higher? Check out these 3 healthcare stocks -- but be careful.
Healthcare's Top Dividend Paying Stocks
Top dividend paying stocks aren't easy to come by in the healthcare sector. Let's have a look at the five high-yielding stocks in healthcare and see if they'd be a good fit for your portfolio over the long term.
3 Value Stocks to Consider for Your Portfolio
After whiffing on Wall Street's quarterly forecasts, these three value stocks could be ripe for the picking.
3 Stocks Near 52-Week Lows Worth Buying
Do these three fallen angels deserve a second chance? You be the judge!
Valuation
Earnings Transcripts
Meridian Bioscience Inc (VIVO) Q4 2021 Earnings Call Transcript
VIVO earnings call for the period ending September 30, 2021.
Meridian Bioscience Inc (VIVO) Q3 2021 Earnings Call Transcript
VIVO earnings call for the period ending June 30, 2021.
Meridian Bioscience Inc (VIVO) Q2 2021 Earnings Call Transcript
VIVO earnings call for the period ending March 31, 2021.
Meridian Bioscience Inc (VIVO) Q1 2021 Earnings Call Transcript
VIVO earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.